These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application. Ivanova M; Artusi C; Boffa GM; Zaninotto M; Plebani M Clin Chim Acta; 2010 Nov; 411(21-22):1632-6. PubMed ID: 20542018 [TBL] [Abstract][Full Text] [Related]
6. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease. Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459 [TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes. Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528 [TBL] [Abstract][Full Text] [Related]
8. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction. Cavalca V; Veglia F; Squellerio I; De Metrio M; Rubino M; Porro B; Moltrasio M; Tremoli E; Marenzi G PLoS One; 2012; 7(11):e48499. PubMed ID: 23185262 [TBL] [Abstract][Full Text] [Related]
9. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology? Busch M; Fleck C; Wolf G; Stein G Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555 [TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976 [TBL] [Abstract][Full Text] [Related]
11. Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation. Claes KJ; Bammens B; Kuypers DR; Meijers B; Naesens M; Sprangers B; Vanrenterghem Y; Lerut E; de Loor H; Evenepoel P Nephrol Dial Transplant; 2014 Oct; 29(10):1965-72. PubMed ID: 24957811 [TBL] [Abstract][Full Text] [Related]
12. The human liver clears both asymmetric and symmetric dimethylarginine. Siroen MP; van der Sijp JR; Teerlink T; van Schaik C; Nijveldt RJ; van Leeuwen PA Hepatology; 2005 Mar; 41(3):559-65. PubMed ID: 15726655 [TBL] [Abstract][Full Text] [Related]
13. Association of asymmetric dimethylarginine and endothelial dysfunction. Böger RH Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027 [TBL] [Abstract][Full Text] [Related]
14. Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nijveldt RJ; Van Leeuwen PA; Van Guldener C; Stehouwer CD; Rauwerda JA; Teerlink T Nephrol Dial Transplant; 2002 Nov; 17(11):1999-2002. PubMed ID: 12401860 [TBL] [Abstract][Full Text] [Related]
15. Accumulation of symmetric dimethylarginine in hepatorenal syndrome. Lluch P; Mauricio MD; Vila JM; Segarra G; Medina P; Del Olmo JA; Rodrigo JM; Serra MA Exp Biol Med (Maywood); 2006 Jan; 231(1):70-5. PubMed ID: 16380646 [TBL] [Abstract][Full Text] [Related]
17. Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Kiechl S; Lee T; Santer P; Thompson G; Tsimikas S; Egger G; Holt DW; Willeit J; Xu Q; Mayr M Atherosclerosis; 2009 Jul; 205(1):261-5. PubMed ID: 19100547 [TBL] [Abstract][Full Text] [Related]
18. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Böger RH Cardiovasc Res; 2003 Oct; 59(4):824-33. PubMed ID: 14553822 [TBL] [Abstract][Full Text] [Related]
19. Asymmetric and Symmetric Dimethylarginines are Markers of Delayed Cerebral Ischemia and Neurological Outcome in Patients with Subarachnoid Hemorrhage. Appel D; Seeberger M; Schwedhelm E; Czorlich P; Goetz AE; Böger RH; Hannemann J Neurocrit Care; 2018 Aug; 29(1):84-93. PubMed ID: 29560598 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of plasma asymmetric and symmetric dimethylarginine levels in liver transplant recipients. Wnuk Z; Kokot F; Kunsdorf-Wnuk A Pol Arch Med Wewn; 2012; 122(7-8):367-73. PubMed ID: 22688059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]